RaySearch Laboratories AB (publ)
Research RaySearch Laboratories AB (publ) (RAY-B) on Bullrun: valuation model: fairly valued, market cap SEK 7.10B, P/E 31.6, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRAY-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryHealth Information Services
- CurrencySEK
- Valuation signalfairly valued
- Market capSEK 7.10B
- P/E31.6
- Dividend yield1.9%
- Financial periodFY2024
- RevenueSEK 1.19B
- Revenue growth16.6%
- Net incomeSEK 203.51M
- Free cash flowSEK 471.97M
- Gross margin91.7%
Valuation Snapshot
Bullrun's latest valuation model marks RaySearch Laboratories AB (publ) as fairly valued; latest market cap is SEK 7.10B; P/E is 31.6; dividend yield is 1.9%.
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems.
Frequently asked questions
Is RaySearch Laboratories AB (publ) overvalued or undervalued?
Bullrun's valuation model currently marks RaySearch Laboratories AB (publ) as fairly valued.
What is RaySearch Laboratories AB (publ)'s market cap?
RaySearch Laboratories AB (publ)'s market capitalization is SEK 7.10B.
What is RaySearch Laboratories AB (publ)'s P/E ratio?
RaySearch Laboratories AB (publ)'s price-to-earnings (P/E) ratio is 31.6.
Does RaySearch Laboratories AB (publ) pay a dividend?
RaySearch Laboratories AB (publ) has a dividend yield of 1.9%.
What does RaySearch Laboratories AB (publ) do?
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics;